Rosuvastatin
Generic Name: Rosuvastatin
Uses & Medical Indications
Reduce LDL cholesterol, triglycerides, increase HDL, slow progression of atherosclerosis
Hyperlipidemia, Prevention of Cardiovascular Disease
Work Mechanism & Pharmacology
Patient Overview of Work Mechanism
Rosuvastatin blocks the liver enzyme that manufactures bad LDL cholesterol, helping clear plaque-forming fats from the bloodstream.
Clinical Mechanism of Action (MoA)
Rosuvastatin competitively inhibits HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis, upregulating hepatic LDL receptors and reducing circulating atherogenic cholesterol.
Dosage & Administration Guidelines
5-40 mg once daily
5-20 mg daily for heterozygous familial hypercholesterolemia (>= 8 yrs)
Start at 5 mg daily
40 mg/day (only for severe hypercholesterolemia)
Start at 5 mg daily; max 10 mg/day if CrCl < 30 mL/min
Contraindicated in active liver disease
Side Effects & Safety Warnings
Myalgia, headache, abdominal pain, nausea, asthenia
Rhabdomyolysis, hepatotoxicity, immune-mediated necrotizing myopathy
Active liver disease, pregnancy, lactation
Increased risk of myopathy/rhabdomyolysis in elderly or with interacting drugs
Interactions (Drugs, Food & Alcohol)
Cyclosporine, gemfibrozil, protease inhibitors, warfarin
N/A
Heavy use increases risk of liver damage
Pregnancy & Breastfeeding Safety
Contraindicated in pregnancy
Contraindicated during breastfeeding
Patient Counseling & Practical Advice
Report unexplained muscle pain, tenderness, or weakness immediately.
Take as soon as remembered. Skip if more than 12 hours late.
Lipid panel, CPK (if muscle symptoms), LFTs
When to Seek Urgent Medical Attention
Seek immediate emergency medical care (call emergency services or proceed to the nearest emergency department) if you experience signs of a life-threatening allergic reaction (anaphylaxis: facial, lip, tongue, or throat swelling causing airway obstruction), severe cutaneous blistering with skin peeling, sudden intense chest pain, or symptoms of overdose.
Content for Rosuvastatin was synthesized from standardized public health monographs, official pharmacopoeias, and health authorities:
- Central Drugs Standard Control Organization (CDSCO) — National List of Essential Medicines
- World Health Organization (WHO) — Model List of Essential Medicines
- Indian Pharmacopoeia Commission (IPC) — Indian Pharmacopoeia Drug Monographs
- National Health Service (NHS) — Medicines A to Z Clinical Guidelines
The information provided on this website is for educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions you may have regarding a medical condition.